Skip to main content

Pathways to Immunologically Mediated Asthma (PIMA)

Trial Status
Current Trial - Enrollment Complete

Summary: 

Study designed to further our understanding of the pathogenesis of asthma exacerbations in children. Children enrolled in the study (n=217) were all asthmatic and primarily Hispanic white. The children were followed for 18 months until they experienced an asthma exacerbation or completed the follow-up without an exacerbation. The time to the first asthma exacerbation was considered the outcome. The acute and convalescent immune phenotype of each asthma exacerbation was documented.

 

Principal Investigator(s)
Research Area
Applied and Basic Research
Disease Type
Allergy, Asthma, Genetics, Immunology